Home Diagnostic Imaging International Corp.
Press Releases  

2014   l   2013   l   2012   l   2011   l   2010   l   2009   l   2008



May 16, 2013
AMI Research Initiates Coverage on Diagnostic Imaging International Corp. with a Speculative Buy Rating of $0.62

Las Vegas, May 16, 2013 -- AMI Research, a leading provider of equity research reports and a subsidiary of Hawk Associates Inc., announced today that it has initiated equity research coverage on Diagnostic Imaging International Corp. (OTCQB:DIIG) with a Speculative Buy rating of $0.62 per share.

AMI president Peter J. D'Agostino said, "We think DIIG is poised for substantial growth with the completion of its first, stand-alone MRI diagnostic facility. Operating MRI facilities offers significant sources of revenue for healthcare providers as the facilities are generally supported by favorable reimbursement rates from insurers and government programs. We contend that DIIG's diagnostic business unit will be the catalyst for the company's significant revenue expansion. In addition, we cannot ignore DIIG's teleradiology business, which yields positive cash-flow."

AMI Research provides an institutional-quality, equity research initiation report detailing DIIG's key statistics, management, growth catalysts, financial outlook, price target, and valuation. The complete eight-page report is available to download for free at the AMI Research website, http://www.amistockreports.com/DIIG_Initiation.pdf


About AMI Research
AMI Research provides equity research coverage for promising companies that do not have traditional Wall Street analyst coverage. Coverage by AMI ensures an objective explanation of all facets of a business and increased exposure to numerous institutional and retail investors seeking reputable investment ideas. AMI combines in-depth, insightful research and customized graphics into detailed analyst reports to create an investment thesis with a four tier rating system and 12-month price target. These reports detail the company's industry, strategic position, core business model, financial history, future growth catalysts and projected financials. Please visit http://www.amistockreports.com. For more information, contact Peter J. D'Agostino, president at 212.541.2465, email to: p.dagostino@amistockreports.com.


Contacts:
AMI Research

Peter J. D'Agostino, 212-541-2465


About Diagnostic Imaging International Corp.
Diagnostic Imaging International Corp., ("DIIG") owns and operates CTS a Teleradiology company, and SMI an MRI clinic. Teleradiology is the process of assessing radiological patient images, such as x-rays, CTs, and MRIs, from one location to another for the purposes of interpretation and/or consultation. CTS provides remote radiology (teleradiology) technology to hospitals and practices, on-call 24 hours a day, 7days a week. CTS connects clients with a global teleradiology network, providing access to global partner facilities and American and Canadian board-certified radiologists. SMI provides full out-patient MRI diagnostic scans and results, and offers its patients both an open MRI and closed 1.5T MRI depending on needs and requirements.

To find out more about Diagnostic Imaging International Corp. (OTCQB: DIIG), visit our website at www.diig.biz. Or contact the Company directly at (877) 331-3444.

Designed by Sherly Ho Design and Associates 
 

Diagnostic Imaging International Corp. (“DIIG”) may from time to time provide links to independent web sites on the Internet containing various information content relative to the Company or its industry. The Company makes no judgment or warranty with respect to the accuracy, timeliness or suitability of the content of other services or sites to which these screens link. A link to a service or site outside of the site on which you are currently located, is not an endorsement of the service or site, its content, or its sponsoring organization. It is further understood that the materials provided on this site are for information purposes only and any references to our specific publicly traded securities contained herein, do not constitute recommendations to buy or sell stock. Any investment you make will be based solely on your own evaluation of your financial circumstances and investment objectives.

Certain statements contained on www.diig.biz, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company's Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company's ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel - including highly qualified executives, management and operational personnel, ability to negotiate favorable current debt and future capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained on DIIG’s web site will, in fact, occur.